Press Releases

2013

Key Cell Mechanics Study Reveals the Role of Nuclear Pore Proteins in Regulating Gene Expression, Contributing Valuable Knowledge to the Fight Against Infectious Diseases, Cancer, and Neurodegenerative Diseases - 2/28/2013
The three-dimensional architecture of a cell’s nucleus, which contains its genetic information, is critical to determining which of a cell’s genes are actually expressed. Using systems and cell...
Daily Planet on Discovery Channel features Stefan Kappe's Malaria Research - 2/22/2013
Discovery Channel's Daily Planet program featured malaria researcher Stefan Kappe and his lab in this six-minute segment. Watch him and other malaria researchers discuss their work towards...

2012

Seattle BioMed received support from the Tres Cantos Open Lab Foundation to identify selective inhibitors of mycobacterial dihydrofolate retuctase - 11/28/2012
Seattle BioMed received support from the Tres Cantos Open Lab Foundation to identify selective inhibitors of mycobacterial dihydrofolate retuctase
Seattle BioMed receives support from the Tres Cantos Open Lab Foundation to identify selective inhibitors of mycobacterial dihydrofolate retuctase - 11/28/2012
Seattle BioMed receives support from the Tres Cantos Open Lab Foundation to identify selective inhibitors of mycobacterial dihydrofolate retuctase
SSGCID and CSGID Pioneer Discovery of New Pathogen Protein Structures - 11/19/2012
The Seattle Structural Genomics Center for Infectious Disease and the Center for Structural Genomics of Infectious Diseases announced today they will receive up to $52.4 million over five years, from...
Malaria Research Breakthrough using Humanized Mice will help in the Discovery of New Drugs and Vaccines - 9/10/2012
Seattle BioMed, Yecuris Corporation, Oregon Health and Science University and The Rockefeller University report findings in the Journal of Clinical Investigation
Seattle BioMed Responds to Global Threat of Untreatable Tuberculosis with Novel Scientific Approaches and Focus on Research Funding - 7/17/2012
Seattle BioMed President Alan Aderem and TB Program Director David Sherman make infectious disease research, systems biology, and expanded funding first priorities for ending TB threat.
Seattle BioMed Adds New Executive Leadership to Accelerate Science - 6/22/2012
Coffman and Brown join Hassler to form expert administrative leadership team, led by Aderem, to 
support the Institute’s infectious disease research strategiesIn his first half year at the helm of...
Scientists Work Together to Achieve Milestone Against Deadly Diseases - 6/5/2012
Solve 1,000 Protein Structures from Infectious Disease Organisms
New Discoveries About Severe Malaria Could Lead To New Interventions - 5/21/2012
Seattle BioMed, University of Copenhagen & University of Edinburgh report findings in PNASSEATTLE, May 21, 2012 — Researchers from Seattle Biomedical Research Institute (Seattle BioMed), the...